Latest stories on VCYT
Veracyte assumed with a Buy at UBS
The Fly61 · neutralanalyst
Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
StockTitan55 · neutralgeneral
Cathie Wood’s ARK Investment buys 47.8K shares of Veracyte today
The Fly63 · neutralgeneral
Veracyte: Diagnostics With Favorable Economics
Seeking Alpha67 · bullishanalyst
Veracyte: Core Growth Funds Prosigna And TrueMRD
Seeking Alpha73 · bullishproduct/pr
Canaccord cuts Veracyte stock price target to $50 on revenue outlook
Investing.com Analyst Ratings38 · neutralanalyst
Veracyte, Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Veracyte Delivers Double-Digit Growth, New Product Launches, and Boosts 2026 Revenue Outlook
July 31, 2026
MarketChameleon73 · bullishearnings
Freedom Capital raises Veracyte stock price target on strong earnings
Investing.com Analyst Ratings67 · bullishanalyst
Veracyte outlines $590M-$596M 2026 revenue guidance while expanding Prosigna and TrueMRD launches
Seeking Alpha67 · bullishproduct/pr
Veracyte, Inc. (VCYT) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
VERACYTE, INC. (VCYT) files 8-K
SEC 8-K50 · neutralgeneral
Veracyte Announces Second Quarter 2026 Financial Results
StockTitan67 · bullishearnings
Veracyte Announces Second Quarter 2026 Financial Results
Business Insider67 · bullishearnings
Veracyte (VCYT) Rises with Upward Guidance Revision and Earnings Beat
Yahoo Finance68 · bullishearnings
Veracyte to Participate in Upcoming Investor Conferences
StockTitan55 · neutralgeneral
Veracyte to Participate in Upcoming Investor Conferences
Business Insider55 · neutralgeneral
Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026 | VCYT Stock News
StockTitan50 · neutralearnings
A Veracyte Insider Sold 24,000 Company Shares for $1.1 Million. Here's a Deeper Look at the Transaction.
The Motley Fool48 · neutralgeneral
What to Know About This $197,000 Veracyte Insider Sale After a 120% Stock Rally
The Motley Fool48 · neutralgeneral
This Top Stock Has Surged. CEO Explains Key To Veracyte's Success.
Investors.com73 · bullishproduct/pr
Veracyte shareholders endorse board, pay and incentive plans
TipRanks50 · neutralgeneral
VERACYTE, INC. (VCYT) files 8-K
SEC 8-K50 · neutralgeneral
Veracyte, Inc. (VCYT) Discusses ASCO Findings From OPTIMA and ENZAMET Phase III Trials in Breast and Prostate Cancer - Slideshow
Seeking Alpha50 · neutralgeneral
Veracyte, Inc. (VCYT) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow
Seeking Alpha50 · neutralgeneral